The Global Partnership for Zero Leprosy is a coalition of individuals and organizations committed to ending leprosy, also known as Hansen’s disease. View Charter

We envision a world with zero leprosy: no disease, no disability, and no discrimination or stigma.


The Global Partnership for Zero Leprosy facilitates alignment of the leprosy community and accelerates effective collaborative action toward the goal of zero leprosy.

We coordinate action in three areas:

  • Accelerating research in new diagnostic and therapeutic tools, interventions, and strategies to interrupt leprosy transmission, prevent disability, and end discrimination and stigma.
  • Partnering with national leprosy programmes to identify and scale up and best practices while  country-led planning to reach zero leprosy.
  • Increasing advocacy and mobilization to prioritize leprosy internationally and needed to reach zero in partnership experienced leprosy.


Sign up for our newsletter to receive monthly updates on our progress.

Our 2022 objectives include:


The Zero Leprosy Research Agenda identifies key thematic areas. Following a series of three workshops, the Partnership will facilitate collaboration on the development and submission of research proposals across three research priority areas. The Partnership will also take further steps toward product development for a leprosy diagnostic tool.


The Partnership will continue Country Model implementation with eight existing country partners and four new country partners. We will continue developing new tools for the Zero Leprosy Country Model in addition to a self-guided version that can be implemented remotely. We will pilot the self-guided model in 2022.


The Partnership will develop and implement a resource mobilization and advocacy strategy for the global leprosy community. The Partnership will also develop a leadership and advocacy curriculum for patient advocates from stigmatizing NTDs.

Our Partners

The Global Partnership for Zero Leprosy Leadership Team includes Novartis; the World Health Organization (WHO), as an observer; the International Federation of Anti-Leprosy Associations (ILEP); the Sasakawa Health Foundation; and the International Association for Integration, Dignity and Economic Advancement (IDEA); as well as the national leprosy programmes of Brazil, Ghana, and India; the International Leprosy Association (ILA); scientific and academic communities; and people who have experienced leprosy. The Secretariat for the Partnership is located at the Task Force for Global Health.